领导力视角:Illumina引领基因组AI行业——Illumina
Leadership Perspectives: Illumina leads the industry in genomic AI - Illumina
生物技术与制药领域的最新动态
Leadership Perspectives: Illumina leads the industry in genomic AI - Illumina
Is Illumina Inc. (ILU) stock a buy on weakness - Portfolio Performance Report & Accurate Buy Signal Alerts - newser.com
Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study - PR Newswire
Illumina To Webcast Upcoming Investor Conference - PR Newswire
Illumina (ILMN): Exploring Valuation Following Recent Share Price Rebound - Yahoo Finance
Illumina, Inc. (NASDAQ:ILMN) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected - simplywall.st
Illumina: An Excellent Profit Margin And The Sequencing Genome Market Will Unlock Value - Seeking Alpha
China to lift 8-month ban on imports of Illumina’s gene sequencers - Times of San Diego
Illumina shares rise as China set to lift sequencer export ban - Fierce Biotech
Illumina’s Constellation and 5-Base Unlock New Depths of DNA Insights - Technology Networks
Illumina says China is lifting export ban - MedTech Dive
Illumina Says China Removed Ban on Importing DNA Sequencers - Bloomberg.com
Illumina Responds to Positive Updates from Chinese Ministry of Commerce - PR Newswire
Illumina (ILMN) Soars 23.4% on Earnings Beat - Yahoo Finance
Barclays Maintains Illumina (ILMN) Underweight Recommendation - Nasdaq
Illumina (ILMN) Returns to Profitability, Undervalued Versus Peers but Growth Lags Market - Yahoo Finance
'Hopeful' We'll Find Long-term Solution On China: Illumina CEO - Bloomberg.com
Illumina sales flat in Q3 amid China headwinds as CEO remains 'in dialogue' with agencies - Fierce Biotech
Why Illumina (ILMN) Stock Is Up Today - Yahoo Finance
Illumina Inc. Q3 Profit Decreases, But Beats Estimates - Nasdaq